BRIEF published on 01/06/2025 at 11:08, 1 year 10 months ago Number of shares and voting rights of Sartorius Stedim Biotech Share Capital Voting Rights Actions AMF Sartorius Stedim Biotech
PRESS RELEASE published on 01/06/2025 at 11:03, 1 year 10 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech S.A. in Aubagne, France declares the total number of shares and voting rights in their issued capital according to regulations Voting Rights Shares Sartorius Stedim Biotech France Aubagne
PRESS RELEASE published on 01/06/2025 at 11:03, 1 year 10 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights in their issued capital as of December 31, 2024 Voting Rights Capital Déclaration Shares Sartorius Stedim Biotech
BRIEF published on 12/03/2024 at 10:43, 1 year 11 months ago Sartorius Stedim Biotech Statement on Share Capital Share Capital Voting Rights Actions AMF Sartorius Stedim
PRESS RELEASE published on 12/03/2024 at 10:38, 1 year 11 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA in Aubagne, France declares total shares and voting rights as of November 30, 2024 Voting Rights Shares Sartorius Stedim Biotech France Aubagne
PRESS RELEASE published on 12/03/2024 at 10:38, 1 year 11 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares number of shares and voting rights in the issued capital as per regulatory requirements Voting Rights Shares Sartorius Stedim Biotech AMF Regulations French Regulatory News
BRIEF published on 11/04/2024 at 10:16, 2 years ago Sartorius Stedim Biotech Statement on Shares and Voting Rights Share Capital Voting Rights Actions AMF Sartorius Stedim
PRESS RELEASE published on 11/04/2024 at 10:11, 2 years ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights in the issued capital. Total shares: 97,330,405. Total voting rights: 165,567,396 Voting Rights Shares Sartorius Stedim Biotech Issued Capital French Regulatory News
BRIEF published on 10/17/2024 at 07:07, 2 years 1 month ago Sartorius Stedim Biotech: Unaudited results for the first nine months of 2024 Financial Results Sartorius Stedim Biotech Outlook 2024 Advanced Therapies Turnover
PRESS RELEASE published on 10/17/2024 at 07:02, 2 years 1 month ago Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2024 Sartorius Stedim Biotech posts unaudited 9-month results for 2024, confirming outlook. Sales revenue 2,029 million euros, EBITDA 565 million euros, strong consumables demand EBITDA Sartorius Stedim Biotech Sales Revenue 9-month Figures Consumables
Published on 11/18/2026 at 00:35, 1 hour 40 minutes ago Route1 Appoints Tom Park to Board of Directors and Announces Board Changes
Published on 11/17/2026 at 23:40, 2 hours 35 minutes ago AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 11/17/2026 at 23:00, 3 hours 15 minutes ago Alset AI Ventures Inc. Announces Extension of Annual General Meeting Deadline
Published on 11/17/2026 at 21:30, 4 hours 45 minutes ago Fairplay Ventures INC. Announces Filing of Filing Statement in Connection With Qualifying Transaction
Published on 11/17/2026 at 15:00, 11 hours 15 minutes ago Secure Blockchain's Agentic Solutions Signs Engineering Company, Expanding Enterprise AI Into Heavy Industry
Published on 11/18/2026 at 01:55, 19 minutes ago WIRobotics and Ottobock Join Forces to Expand Access to Wearable Robots Across North America
Published on 11/18/2026 at 01:40, 34 minutes ago AMPERA and Berto Announce Proposed Business Combination to Accelerate Advanced Energy Technology Development and Commercialization
Published on 11/17/2026 at 23:13, 3 hours 1 minute ago EQS-Adhoc: M1 Kliniken AG plans move to the Prime Standard in 2027 and raises EBIT margin target for its Beauty segment to at least 25%
Published on 11/17/2026 at 21:12, 5 hours 2 minutes ago EQS-Adhoc: JDC Group AG: Adjustment of Full-Year Guidance
Published on 11/17/2026 at 20:00, 6 hours 14 minutes ago EQS-Adhoc: Sasol Financing USA LLC: SASOL ANNOUNCES RESULTS OF THE INVITATION TO REPURCHASE OUTSTANDING US$750 MILLION 4.5% GUARANTEED SENIOR UNSECURED CONVERTIBLE BONDS DUE 2027
Published on 11/17/2026 at 18:00, 8 hours 15 minutes ago 20261117 - Accor - Accor to increase its stake in Ennismore
Published on 11/17/2026 at 17:45, 8 hours 30 minutes ago EURAZEO COMPLETES THE SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT ALONGSIDE PARTNERS GROUP
Published on 11/17/2026 at 07:40, 18 hours 34 minutes ago SUEZ INTERNATIONAL SAS COMPLETES THE SALE OF C.10.65 MILLION SHARES OF ACEA S.P.A.
Published on 11/17/2026 at 07:30, 18 hours 45 minutes ago PR_Carrefour reaffirms its confidence in the hypermarket model, a pillar of its performance
Published on 11/17/2026 at 06:55, 19 hours 20 minutes ago Recticel Group recognised by TIME among the World's Best Companies for Sustainable Growth 2027